RecruitingNot applicableNCT04819217
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
Studying Autosomal dominant tubulointerstitial kidney disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Taiwan University Hospital
- Principal Investigator
- Chau chung Wu, Ph.D., M.DNational Taiwan University Hospital
- Intervention
- Active bamboo charcoal(dietary_supplement)
- Eligibility
- 20 years · All sexes
- Timeline
- 2020 – 2030
Study locations (1)
- NTUH, Taipei, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04819217 on ClinicalTrials.govOther trials for Autosomal dominant tubulointerstitial kidney disease
Additional recruiting or active studies for the same condition.
See all trials for Autosomal dominant tubulointerstitial kidney disease →